首页> 美国卫生研究院文献>other >Rapid Microbial Sample Preparation from Blood Using a Novel Concentration Device
【2h】

Rapid Microbial Sample Preparation from Blood Using a Novel Concentration Device

机译:使用新型浓缩装置从血液中快速制备微生物样品

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Appropriate care for bacteremic patients is dictated by the amount of time needed for an accurate diagnosis. However, the concentration of microbes in the blood is extremely low in these patients (1–100 CFU/mL), traditionally requiring growth (blood culture) or amplification (e.g., PCR) for detection. Current culture-based methods can take a minimum of two days, while faster methods like PCR require a sample free of inhibitors (i.e., blood components). Though commercial kits exist for the removal of blood from these samples, they typically capture only DNA, thereby necessitating the use of blood culture for antimicrobial testing. Here, we report a novel, scaled-up sample preparation protocol carried out in a new microbial concentration device. The process can efficiently lyse 10 mL of bacteremic blood while maintaining the microorganisms’ viability, giving a 30‑μL final output volume. A suite of six microorganisms (Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Pseudomonas aeruginosa, and Candida albicans) at a range of clinically relevant concentrations was tested. All of the microorganisms had recoveries greater than 55% at the highest tested concentration of 100 CFU/mL, with three of them having over 70% recovery. At the lowest tested concentration of 3 CFU/mL, two microorganisms had recoveries of ca. 40–50% while the other four gave recoveries greater than 70%. Using a Taqman assay for methicillin-sensitive S. aureus (MSSA)to prove the feasibility of downstream analysis, we show that our microbial pellets are clean enough for PCR amplification. PCR testing of 56 spiked-positive and negative samples gave a specificity of 0.97 and a sensitivity of 0.96, showing that our sample preparation protocol holds great promise for the rapid diagnosis of bacteremia directly from a primary sample.
机译:对细菌患者的适当护理取决于准确诊断所需的时间。但是,这些患者的血液中微生物浓度极低(1–100 CFU / mL),传统上需要生长(血液培养)或扩增(例如PCR)进行检测。当前的基于培养的方法可能至少需要两天的时间,而更快的方法(如PCR)则需要不含抑制剂(即血液成分)的样品。尽管存在用于从这些样品中去除血液的商业试剂盒,但是它们通常仅捕获DNA,因此必须使用血液培养物进行抗微生物测试。在这里,我们报告了在新型微生物浓缩装置中进行的新型,按比例放大的样品制备方案。该过程可有效裂解10 mL细菌血,同时保持微生物的活力,最终输出量为30 µL。测试了一系列临床相关浓度范围内的六种微生物(金黄色葡萄球菌,肺炎链球菌,大肠杆菌,流感嗜血杆菌,铜绿假单胞菌和白色念珠菌)。在最高测试浓度100 CFU / mL下,所有微生物的回收率均大于55%,其中三个微生物的回收率超过70%。在3 CFU / mL的最低测试浓度下,两种微生物的回收率约为。 40–50%,而其他四个的回收率大于70%。使用Taqman测定法对甲氧西林敏感的金黄色葡萄球菌(MSSA)进行下游分析的可行性,我们证明我们的微生物沉淀足够干净以进行PCR扩增。对56个加标的阳性和阴性样品进行PCR检测,特异性为0.97,灵敏度为0.96,这表明我们的样品制备方案对直接从原始样品快速诊断菌血症具有广阔的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号